Stephen D Collins

Title: The Innovations of Stephen D Collins

Introduction

Stephen D Collins is a notable inventor based in Lake Forest, IL (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work primarily focuses on developing modified release pharmaceutical compositions and methods for treating neurological disorders.

Latest Patents

One of his latest patents is titled "Modified release pharmaceutical compositions of huperzine and methods of using the same." This invention discloses pharmaceutical compositions that allow for the modified release of huperzine, enabling dosing at higher therapeutic thresholds while avoiding rapid serum peak plasma levels. This innovation helps to mitigate the adverse effects, such as nausea and vomiting, associated with immediate release pharmaceutical compositions. Another significant patent is "Halogenated derivatives of morphinans and uses thereof." This invention encompasses improved morphinan compositions and methods for modulating neuropathic pain and opioid-induced glial activation, providing new avenues for treatment beyond current knowledge in the field.

Career Highlights

Throughout his career, Stephen has worked with reputable companies, including Lundbeck Pharmaceuticals LLC and Supernus Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Stephen has collaborated with notable professionals in the field, including James C Cloyd and Angela Birnbaum. These collaborations have further enriched his work and contributions to pharmaceutical advancements.

Conclusion

Stephen D Collins is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of neurological disorders. His innovative patents reflect his commitment to advancing medical science and improving patient outcomes.